Merck & Statistics
Share Statistics
Merck & has 2.52B
shares outstanding. The number of shares has increased by -0.27%
in one year.
| Shares Outstanding | 2.52B |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | -0.14% |
| Owned by Institutions (%) | 77.8% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 877 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 41.93M, so 1.66% of the outstanding
shares have been sold short.
| Short Interest | 41.93M |
| Short % of Shares Out | 1.66% |
| Short % of Float | 1.66% |
| Short Ratio (days to cover) | 2.33 |
Valuation Ratios
The PE ratio is 14.72 and the forward
PE ratio is 8.41.
Merck &'s PEG ratio is
0.
| PE Ratio | 14.72 |
| Forward PE | 8.41 |
| PS Ratio | 3.93 |
| Forward PS | 2.9 |
| PB Ratio | 5.44 |
| P/FCF Ratio | 13.92 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Merck & has an Enterprise Value (EV) of 275.75B.
| EV / Sales | 4.3 |
| EV / EBITDA | 10.24 |
| EV / EBIT | 12.84 |
| EV / FCF | 15.24 |
Financial Position
The company has a current ratio of 1.36,
with a Debt / Equity ratio of 0.8.
| Current Ratio | 1.36 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.8 |
| Debt / EBITDA | 1.38 |
| Debt / FCF | 2.05 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 36.96% and Return on Invested Capital is 21.35%.
| Return on Equity | 36.96% |
| Return on Assets | 14.62% |
| Return on Invested Capital | 21.35% |
| Revenue Per Employee | $879,013.7 |
| Profits Per Employee | $234,479.45 |
| Employee Count | 73,000 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.49 |
Taxes
| Income Tax | 2.8B |
| Effective Tax Rate | 14.06% |
Stock Price Statistics
The stock price has increased by -35.05% in the
last 52 weeks. The beta is 0.42, so Merck &'s
price volatility has been higher than the market average.
| Beta | 0.42 |
| 52-Week Price Change | -35.05% |
| 50-Day Moving Average | 87.08 |
| 200-Day Moving Average | 101.17 |
| Relative Strength Index (RSI) | 48.54 |
| Average Volume (20 Days) | 17,504,756 |
Income Statement
In the last 12 months, Merck & had revenue of 64.17B
and earned 17.12B
in profits. Earnings per share was 6.74.
| Revenue | 64.17B |
| Gross Profit | 48.98B |
| Operating Income | 22.69B |
| Net Income | 17.12B |
| EBITDA | 26.94B |
| EBIT | 22.77B |
| Earnings Per Share (EPS) | 6.74 |
Full Income StatementBalance Sheet
The company has 13.24B in cash and 37.11B in
debt, giving a net cash position of -23.87B.
| Cash & Cash Equivalents | 13.24B |
| Total Debt | 37.11B |
| Net Cash | -23.87B |
| Retained Earnings | n/a |
| Total Assets | 98.35B |
| Working Capital | 10.33B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 21.47B
and capital expenditures -3.37B, giving a free cash flow of 18.1B.
| Operating Cash Flow | 21.47B |
| Capital Expenditures | -3.37B |
| Free Cash Flow | 18.1B |
| FCF Per Share | 7.15 |
Full Cash Flow StatementMargins
Gross margin is 76.32%, with operating and profit margins of 35.36% and 26.68%.
| Gross Margin | 76.32% |
| Operating Margin | 35.36% |
| Pretax Margin | 31.07% |
| Profit Margin | 26.68% |
| EBITDA Margin | 41.98% |
| EBIT Margin | 35.36% |
| FCF Margin | 28.2% |
Dividends & Yields
MRK pays an annual dividend of $3.16,
which amounts to a dividend yield of 3.33%.
| Dividend Per Share | $3.16 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | 5.19% |
| Payout Ratio | 45.93% |
| Earnings Yield | 6.8% |
| FCF Yield | 7.18% |
Dividend DetailsAnalyst Forecast
The average price target for MRK is $111,
which is 34% higher than the current price. The consensus rating is "Buy".
| Price Target | $111 |
| Price Target Difference | 34% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Stock ForecastsStock Splits
The last stock split was on Jun 3, 2021. It was a
forward
split with a ratio of 131:125.
| Last Split Date | Jun 3, 2021 |
| Split Type | forward |
| Split Ratio | 131:125 |
Scores
| Altman Z-Score | 4.99 |
| Piotroski F-Score | 7 |
